BDBM37585 MLS000117493::N-[2-(1-cyclohexenyl)ethyl]-6-(dimethylsulfamoyl)-1-ethyl-4-oxo-3-quinolinecarboxamide::N-[2-(cyclohexen-1-yl)ethyl]-6-(dimethylsulfamoyl)-1-ethyl-4-keto-quinoline-3-carboxamide::N-[2-(cyclohexen-1-yl)ethyl]-6-(dimethylsulfamoyl)-1-ethyl-4-oxidanylidene-quinoline-3-carboxamide::N-[2-(cyclohexen-1-yl)ethyl]-6-(dimethylsulfamoyl)-1-ethyl-4-oxoquinoline-3-carboxamide::SMR000094441::cid_5307635

SMILES CCn1cc(C(=O)NCCC2=CCCCC2)c(=O)c2cc(ccc12)S(=O)(=O)N(C)C

InChI Key InChIKey=HJTABMAEVMBUTK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 37585   

TargetHuntingtin(Homo sapiens (Human))
Columbia University Molecular Screening Center

Curated by PubChem BioAssay
LigandPNGBDBM37585(MLS000117493 | N-[2-(1-cyclohexenyl)ethyl]-6-(dime...)
Affinity DataIC50: >8.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair
In DepthDetails PCBioAssay